This content is in French.
Male breast cancer: can we still rely on extrapolating data from women?
24 septembre 2026
Breast cancer is overwhelmingly associated with women. Yet around 1%
of breast cancers occur in men, and incidence has increased over recent
decades. Despite this, male-specific data remain scarce. As a result,
management still relies heavily on recommendations and clinical trials
conducted in women.
A review published in The Oncologist in 2026 summarizes the available evidence and raises a central question: to what extent can practices established in female breast cancer truly be extrapolated to men?
A review published in The Oncologist in 2026 summarizes the available evidence and raises a central question: to what extent can practices established in female breast cancer truly be extrapolated to men?
Sign in to read the rest
Reserved for healthcare professionals, free registration.
Scientific reference
Liu B, Michel AM, Mundi PS, et al. Male breast cancer: from extrapolated practice to evidence-based care. The Oncologist. 2026;31:oyag318
View the source
